Lowers the risk of MI, stroke, revascularization procedures, and angina. ANDA 91650, held by Dr Reddys Labs Ltd. Atorvastatin Calcium.
As of Nov 16, 2026, ANDA 91650 (Atorvastatin Calcium), held by Dr Reddys Labs Ltd, was first approved by FDA on Jul 17, 2012, with 12 approved supplements and 0 published complete response letters.
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. In patients with CHD or multiple risk factors for CHD, atorvastatin calcium tablets can be started simultaneously with diet.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 17, 2012 | Original application | Approved |
| Atorvastatin CalciumEQ 10MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 20MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 40MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Apr 25, 2023 | Supplement 24Labeling · Standard review | Approved | None posted |
| May 18, 2021 | Supplement 18Labeling · Standard review | Approved | None posted |
| May 18, 2021 | Supplement 19Labeling · Standard review | Approved | None posted |
| Oct 13, 2020 | Supplement 16Labeling · Standard review | Approved | None posted |
| Oct 13, 2020 | Supplement 17Labeling · Standard review | Approved | None posted |
| Oct 22, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Oct 22, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Oct 22, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Feb 24, 2016 | Supplement 7Labeling · Standard review | Approved | None posted |
| Nov 5, 2014 | Supplement 5Labeling · Standard review | Approved | None posted |
| Dec 29, 2012 | Supplement 2Labeling · Standard review | Approved | None posted |
| Nov 23, 2012 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jul 17, 2012 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters